Selventa Announces a Research Agreement to Understand Mechanisms of Disease
2/27/2012 6:32:19 AM
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Selventa™, a personalized healthcare company focused on stratification of patients and development of predictive biomarker panels based on disease-driving mechanisms, today announced a research agreement in the area of immunological disease with Janssen Research & Development, LLC. The focus of this multi-year research agreement includes development of disease models using diverse biologic data to elaborate disease-relevant mechanisms and identify potential new drug discovery opportunities.
comments powered by